Regenerative Medicine Today Podcast #25

Regenerative Medicine Today #25

Regenerative Medicine Today welcomes Dr. Yoram Vodovotz, who discusses the research that he and his colleagues are pursuing to model inflammatory responses in the body. They have used these models to successfully predict the outcomes of drug trials.

While scientists and clinicians can’t know in advance what the outcome of a drug trial is, modeling and simulation can be a great tool to give a preliminary look. Such simulated clinical trials are attractive, as traditional drug trials are time consuming and may cost $50 -$100 million. Through modeling, it is possible to rule out which drugs may not work well in advance of the traditional drug trial. In addition the modeling tools of Dr. Vodovotz and his colleagues can be an asset in rational drug design, helping to define what characteristics the new drug should have.

For more information about Dr. Vodovotz, please Click Here.

For more information about the McGowan Institute for Regenerative Medicine, visit:

McGowan Institute Research Site

McGowan Institute Patient Site

McGowan Institute on Facebook

Hosts John Murphy and Leah Kauffman

Subscribe to the Podcast Feed.

Download | Duration: 00:52:57


What did you think of this article?

  • Trackbacks are closed for this post.
  • No comments exist for this post.
Leave a comment

Comments are closed.